Literature DB >> 16909906

Epimutations in human disease.

B Horsthemke1.   

Abstract

Epigenetics is the study of genes during development. Gene expression states are set by transcriptional activators and repressors and locked in by cell-heritable chromatin states. Inappropriate expression or repression of genes can change developmental trajectories and result in disease. Aberrant chromatin states leading to aberrant gene expression patterns (epimutations) have been detected in several recognizable syndromes as well as in cancer. They can occur secondary to a DNA mutation in a cis- or trans-acting factor, or as a "true" or primary epimutation in the absence of any DNA sequence change. Primary epimutations often occur after fertilization and lead to somatic mosaicism. It has been estimated that the rate of primary epimutations is one or two orders of magnitude greater than somatic DNA mutation. Therefore, the contribution of epimutations to human disease is probably underestimated.

Entities:  

Mesh:

Year:  2006        PMID: 16909906     DOI: 10.1007/3-540-31181-5_4

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  32 in total

1.  Primary epimutations introduced during intracytoplasmic sperm injection (ICSI) are corrected by germline-specific epigenetic reprogramming.

Authors:  Eric de Waal; Yukiko Yamazaki; Puraskar Ingale; Marisa Bartolomei; Ryuzo Yanagimachi; John R McCarrey
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-27       Impact factor: 11.205

Review 2.  Constitutional epimutation as a mechanism for cancer causality and heritability?

Authors:  Megan P Hitchins
Journal:  Nat Rev Cancer       Date:  2015-09-18       Impact factor: 60.716

3.  Extreme methylation values of imprinted genes in human abortions and stillbirths.

Authors:  Galyna Pliushch; Eberhard Schneider; Daniela Weise; Nady El Hajj; Achim Tresch; Larissa Seidmann; Wiltrud Coerdt; Annette M Müller; Ulrich Zechner; Thomas Haaf
Journal:  Am J Pathol       Date:  2010-01-21       Impact factor: 4.307

Review 4.  Dark matters in AMD genetics: epigenetics and stochasticity.

Authors:  Leonard M Hjelmeland
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-01       Impact factor: 4.799

Review 5.  Epigenetic mechanisms of drug resistance in fungi.

Authors:  Zanetta Chang; Vikas Yadav; Soo Chan Lee; Joseph Heitman
Journal:  Fungal Genet Biol       Date:  2019-07-17       Impact factor: 3.495

Review 6.  DNA Methylation and Susceptibility to Autism Spectrum Disorder.

Authors:  Martine W Tremblay; Yong-Hui Jiang
Journal:  Annu Rev Med       Date:  2019-01-27       Impact factor: 13.739

7.  Gonadotropin stimulation contributes to an increased incidence of epimutations in ICSI-derived mice.

Authors:  Eric de Waal; Yukiko Yamazaki; Puraskar Ingale; Marisa S Bartolomei; Ryuzo Yanagimachi; John R McCarrey
Journal:  Hum Mol Genet       Date:  2012-07-16       Impact factor: 6.150

8.  A Survey of Rare Epigenetic Variation in 23,116 Human Genomes Identifies Disease-Relevant Epivariations and CGG Expansions.

Authors:  Paras Garg; Bharati Jadhav; Oscar L Rodriguez; Nihir Patel; Alejandro Martin-Trujillo; Miten Jain; Sofie Metsu; Hugh Olsen; Benedict Paten; Beate Ritz; R Frank Kooy; Jozef Gecz; Andrew J Sharp
Journal:  Am J Hum Genet       Date:  2020-09-15       Impact factor: 11.025

9.  Spatial, temporal and interindividual epigenetic variation of functionally important DNA methylation patterns.

Authors:  Eberhard Schneider; Galyna Pliushch; Nady El Hajj; Danuta Galetzka; Alexander Puhl; Martin Schorsch; Katrin Frauenknecht; Thomas Riepert; Achim Tresch; Annette M Müller; Wiltrud Coerdt; Ulrich Zechner; Thomas Haaf
Journal:  Nucleic Acids Res       Date:  2010-03-01       Impact factor: 16.971

10.  The human retinoblastoma gene is imprinted.

Authors:  Deniz Kanber; Tea Berulava; Ole Ammerpohl; Diana Mitter; Julia Richter; Reiner Siebert; Bernhard Horsthemke; Dietmar Lohmann; Karin Buiting
Journal:  PLoS Genet       Date:  2009-12-24       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.